- Home
- IVDA vs TCRT Comparison
IVDA vs TCRT Comparison
Compare IVDA & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- TCRT
- Stock Information
- Founded
- IVDA 2003
- TCRT 1998
- Country
- IVDA United States
- TCRT United States
- Employees
- IVDA N/A
- TCRT N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- TCRT Health Care
- Exchange
- IVDA Nasdaq
- TCRT Nasdaq
- Market Cap
- IVDA 4.3M
- TCRT 4.8M
- IPO Year
- IVDA N/A
- TCRT N/A
- Fundamental
- Price
- IVDA $1.47
- TCRT $2.32
- Analyst Decision
- IVDA
- TCRT
- Analyst Count
- IVDA 0
- TCRT 0
- Target Price
- IVDA N/A
- TCRT N/A
- AVG Volume (30 Days)
- IVDA 268.2K
- TCRT 339.2K
- Earning Date
- IVDA 11-13-2025
- TCRT 11-13-2025
- Dividend Yield
- IVDA N/A
- TCRT N/A
- EPS Growth
- IVDA N/A
- TCRT N/A
- EPS
- IVDA N/A
- TCRT N/A
- Revenue
- IVDA $7,142,302.00
- TCRT $6,000.00
- Revenue This Year
- IVDA $340.48
- TCRT $5,680,500.00
- Revenue Next Year
- IVDA N/A
- TCRT N/A
- P/E Ratio
- IVDA N/A
- TCRT N/A
- Revenue Growth
- IVDA 88.96
- TCRT N/A
- 52 Week Low
- IVDA $1.27
- TCRT $1.31
- 52 Week High
- IVDA $8.05
- TCRT $6.20
- Technical
- Relative Strength Index (RSI)
- IVDA 51.14
- TCRT 51.09
- Support Level
- IVDA $1.36
- TCRT N/A
- Resistance Level
- IVDA $1.62
- TCRT $2.39
- Average True Range (ATR)
- IVDA 0.10
- TCRT 0.19
- MACD
- IVDA -0.07
- TCRT -0.01
- Stochastic Oscillator
- IVDA 88.69
- TCRT 95.08
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.